Hirokazu Ogino 荻野広和

… Alternative Names

OGINO Hirokazu 荻野広和

Less

Researcher Number	20745294
Affiliation (Current)	2025: 徳島大学, 病院, 講師
Affiliation (based on the past Project Information) *help	2022 – 2024: 徳島大学, 病院, 講師 2018 – 2019: 徳島大学, 大学院医歯薬学研究部(医学域), 助教 2016 – 2017: 徳島大学, 大学院医歯薬学研究部(医学系), 助教 2015: 徳島大学, 大学病院, 特任助教
Review Section/Research Field	Principal Investigator Respiratory organ internal medicine / Basic Section 50020:Tumor diagnostics and therapeutics-related Except Principal Investigator Basic Section 50010:Tumor biology-related / Respiratory organ internal medicine / Basic Section 53030:Respiratory medicine-related
Keywords	Principal Investigator がん免疫療法 / 腫瘍内投与 / 樹状細胞 / 免疫チェックポイント阻害薬 / 分子細胞呼吸器学 / 免疫療法 / 線維細胞 / 肺癌 / 癌幹細胞 / 肝転移 … More Except Principal Investigator … More 肺がん / 線維細胞 / 血管新生 / 1細胞解析 / 破骨細胞様マクロファージ / CD200 / 抗原提示細胞 / hot tumor誘導 / ヘパラナーゼ / 細胞外マトリクス / fibrocyte / 免疫チェックポイント阻害薬 / 癌 / 薬剤耐性 / 血小板由来成長因子 / 悪性胸膜中皮腫 / 肺癌 / 血管新生阻害薬耐性 / 免疫チェックポイント分子 / がん免疫 / 免疫チェックポイント / がん幹細胞 Less

ヘパラナーゼ制御によるhot tumor誘導と新規がん複合免疫療法の創出
- Principal Investigator
  
  尾崎領彦
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  The University of Tokushima
腫瘍内線維細胞における時計遺伝子の機能解析と新規複合がん免疫療法開発への応用
- Principal Investigator
  
  三橋惇志
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  The University of Tokushima
腫瘍内免疫療法を用いた新規複合がん免疫療法の効果規定因子を同定する試みPrincipal Investigator
- Principal Investigator
  
  荻野広和
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  The University of Tokushima
肺がん・中皮腫における新たな抗原提示細胞の同定から革新的複合がん免疫療法への展開
- Principal Investigator
  
  西岡安彦
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  The University of Tokushima
The fibrocyte research for clarifying and overcoming the resistance against anti-angiogenesis therapy in lung cancer
- Principal Investigator
  
  GOTO Hisatsugu
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  The University of Tokushima
Analyses of the immuno-modulatory function of fibrocytes in tumor immunityPrincipal Investigator
- Principal Investigator
  
  OGINO Hirokazu
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  The University of Tokushima
Novel target cells in tumor microenvironment of lung cancer: focusing on fibrocytes to overcome drug resistance and develop the innovative therapy
- Principal Investigator
  
  NISHIOKA Yasuhiko
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  The University of Tokushima
The role of cancer stem cell-like sphere forming cells in multi-organ metastasis of lung cancerPrincipal Investigator
- Principal Investigator
  
  OGINO Hirokazu
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  The University of Tokushima

All 2024 2023 2022 2019 2018 2017 2016 2015

All Journal Article Presentation

[Journal Article] An increased relative eosinophil count as a predictive dynamic biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors2023
- Author(s)
  Takeuchi Eiji、Ogino Hirokazu、Kondo Kensuke、Okano Yoshio、Ichihara Seiya、Kunishige Michihiro、Kadota Naoki、Machida Hisanori、Hatakeyama Nobuo、Naruse Keishi、Nokihara Hiroshi、Shinohara Tsutomu、Nishioka Yasuhiko
- Journal Title
  
  Thoracic Cancer
  
  Volume: 15 Issue: 3 Pages: 248-257
- DOI
  10.1111/1759-7714.15191
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24340
[Journal Article] Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies2023
- Author(s)
  Kozai Hiroyuki、Ogino Hirokazu、Mitsuhashi Atsushi、Nguyen Na Thi、Tsukazaki Yuki、Yabuki Yohei、Ozaki Ryohiko、Yoneda Hiroto、Sato Seidai、Hanibuchi Masaki、Shinohara Tsutomu、Nokihara Hiroshi、Nishioka Yasuhiko
- Journal Title
  
  Thoracic Cancer
  
  Volume: 15 Issue: 5 Pages: 369-378
- DOI
  10.1111/1759-7714.15200
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24340
[Journal Article] A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer2023
- Author(s)
  Yabuki Y, Hanibuchi M, Takeuchi E, Haku T, Kanematsu T, Nishimura N, Toyoda Y, Mitsuhashi A, Otsuka K, Sato S, Goto H, Yoneda H, Ogino H, Nokihara H, Tsutomu S, Nishioka Y
- Journal Title
  
  Thorac Cancer
  
  Volume: 14(32) Issue: 32 Pages: 3232-3239
- DOI
  10.1111/1759-7714.15115
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23H00453, KAKENHI-PROJECT-23K24340
[Journal Article] Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors2023
- Author(s)
  Takeuchi Eiji、Kondo Kensuke、Okano Yoshio、Ichihara Seiya、Kunishige Michihiro、Kadota Naoki、Machida Hisanori、Hatakeyama Nobuo、Naruse Keishi、Ogino Hirokazu、Nokihara Hiroshi、Shinohara Tsutomu、Nishioka Yasuhiko
- Journal Title
  
  Thoracic Cancer
  
  Volume: 14 Issue: 30 Pages: 3042-3050
- DOI
  10.1111/1759-7714.15100
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K24340
[Journal Article] Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade2023
- Author(s)
  Mitsuhashi Atsushi、Koyama Kazuya、Ogino Hirokazu、Afroj Tania、Nguyen Na Thi、Yoneda Hiroto、Otsuka Kenji、Sugimoto Masamichi、Kondoh Osamu、Nokihara Hiroshi、Hanibuchi Masaki、Takizawa Hiromitsu、Shinohara Tsutomu、Nishioka Yasuhiko
- Journal Title
  
  Cell Reports
  
  Volume: 42 Issue: 3 Pages: 112162-112162
- DOI
  10.1016/j.celrep.2023.112162
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08542, KAKENHI-PROJECT-23K24340, KAKENHI-PROJECT-22K16302
[Journal Article] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer2023
- Author(s)
  Takeuchi Eiji、Kondo Kensuke、Okano Yoshio、Kunishige Michihiro、Kondo Yoshihiro、Kadota Naoki、Machida Hisanori、Hatakeyama Nobuo、Naruse Keishi、Ogino Hirokazu、Nokihara Hiroshi、Shinohara Tsutomu、Nishioka Yasuhiko
- Journal Title
  
  Journal of Cancer Research and Clinical Oncology
  
  Volume: 149 Issue: 7 Pages: 3139-3147
- DOI
  10.1007/s00432-022-04215-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24340
[Journal Article] Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL82023
- Author(s)
  Numasaki Muneo、Ito Koyu、Takagi Kiyoshi、Nagashima Kengo、Notsuda Hirotsugu、Ogino Hirokazu、Ando Rika、Tomioka Yoshihisa、Suzuki Takashi、Okada Yoshinori、Nishioka Yasuhiko、Unno Michiaki
- Journal Title
  
  Cellular Immunology
  
  Volume: 383 Pages: 104652-104652
- DOI
  10.1016/j.cellimm.2022.104652
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K24340
[Journal Article] Antipodoplanin antibody enhances the antitumor effects of CTLA‐4 blockade against malignant mesothelioma by natural killer cells2023
- Author(s)
  Yoneda Hiroto、Mitsuhashi Atsushi、Yoshida Aito、Ogino Hirokazu、Itakura Satoshi、Nguyen Na Thi、Nokihara Hiroshi、Sato Seidai、Shinohara Tsutomu、Hanibuchi Masaki、Abe Shinji、Kaneko Mika K.、Kato Yukinari、Nishioka Yasuhiko
- Journal Title
  
  Cancer Science
  
  Volume: 115 Issue: 2 Pages: 357-368
- DOI
  10.1111/cas.16046
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24340
[Journal Article] Analysis of the chemotactic factors for tumor?infiltrating fibrocytes and their prognostic significances in lung cancer2022
- Author(s)
  Tobiume Makoto, Mitsuhashi Atsushi, Saijo Atsuro, Ogino Hirokazu, Afroj Tania, Ogawa Hirohisa, Goto Hisatsugu, Sato Seidai, Abe Akane, Haji Keiko, Ozaki Ryohiko, Takizawa Hiromitsu, Nishioka Yasuhiko
- Journal Title
  
  Oncology Letters
  
  Volume: 24 Issue: 5 Pages: 417-417
- DOI
  10.3892/ol.2022.13537
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K24340
[Journal Article] S‐1 eliminates <scp>MDSCs</scp> and enhances the efficacy of <scp>PD</scp> ‐1 blockade via regulation of tumor‐derived Bv8 and <scp>S100A8</scp> in thoracic tumor2022
- Author(s)
  Nguyen Na T.、Mitsuhashi Atsushi、Ogino Hirokazu、Kozai Hiroyuki、Yoneda Hiroto、Afroj Tania、Sato Seidai、Nokihara Hiroshi、Shinohara Tsutomu、Nishioka Yasuhiko
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 2 Pages: 384-398
- DOI
  10.1111/cas.15620
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08542, KAKENHI-PROJECT-23K24340
[Journal Article] Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumonias.2019
- Author(s)
  Atsuro Saijo, Masaki Hanibuchi, Hirokazu Ogino, Kenji Otsuka, Hisatsugu Goto, Hiroshi Nokihara, Yasuhiko Nishioka
- Journal Title
  
  Molecular and Clinical Oncology
  
  Volume: 10 Pages: 541-546
- DOI
  10.3892/mco.2019.1828
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16H05309, KAKENHI-PROJECT-19H03668
[Journal Article] がん転移の臨床研究の歴史と展望2017
- Author(s)
  荻野広和, 西岡安彦
- Journal Title
  
  日本臨牀
  
  Volume: 75 Pages: 15-20
- Data Source
  KAKENHI-PROJECT-16H05309
[Journal Article] Primary Pulmonary Synovial Sarcoma Showing a Prolonged Survival with Multimodality Therapy2016
- Author(s)
  Ogino H, Hanibuchi M, Takizawa H, Sakiyama S, Sumitomo H, Iwamoto S, Ikushima H, Nakajima K, Nagahiro H, Yamago T, Toyoda Y, Bando Y, Nishioka Y
- Journal Title
  
  Intern. Med.
  
  Volume: 55 Issue: 4 Pages: 381-387
- DOI
  10.2169/internalmedicine.55.5169
- NAID
  130005125790
- ISSN
  0918-2918, 1349-7235
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05309, KAKENHI-PROJECT-26670418
[Journal Article] Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital.2016
- Author(s)
  Ogino H, Hanibuchi M, Kakiuchi S, Saojo A, Tezuka T, Toyoda Y, Tobiume M, Otsuka K, Sakaguchi S, Goto H, Arisawa K, Nishioka Y.
- Journal Title
  
  J Med Invest
  
  Volume: 63(3,4) Issue: 3.4 Pages: 286-293
- DOI
  10.2152/jmi.63.286
- NAID
  130005245830
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05309, KAKENHI-PROJECT-26670418
[Presentation] Fluoropyrimidine has a potential to be an immunologically optimal partner ofimmunotherapy for thoracic malignancies2024
- Author(s)
  Hirokazu Ogino、Nguyen Thi Na、Hiroyuki Kozai、Atsushi Mitsuhashi、Yuki Tsukazaki、Yohei Yabuki、Ryohiko Ozaki、Hiroshi Nokihara、Masaki Hanibuchi、Yasuhiko Nishioka
- Organizer
  第21回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 腫瘍内 fibrocyte の同定と制御による新規がん治療開発への橋渡し研究2023
- Author(s)
  三橋惇志、小山壱也、アフローズタニア、西條敦郎、飛梅亮、荻野広和、杉本正道、根東攝、軒原浩、西岡安彦
- Organizer
  第82回日本癌学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] The novel prognostic system for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer2023
- Author(s)
  Hirokazu Ogino、Kensuke Kondo、Atsushi Mitsuhashi、Yuki Tsukazaki、Ryohiko Ozaki、Yohei Yabuki、Hiroto Yoneda、Hiroshi Nokihara、Yasuhiko Nishioka
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 胸部腫瘍におけるfibrocyteの同定と新規治療標的としての展開2023
- Author(s)
  三橋惇志、荻野広和、米田浩人、軒原浩、西岡安彦
- Organizer
  第64回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 腫瘍内 fibrocyte 遊走・分化制御がもたらす腫瘍免疫微小環境への影響2023
- Author(s)
  三橋惇志、小山壱也、荻野広和、杉本正道、根東攝、軒原浩、西岡安彦
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 胸部悪性腫瘍において免疫チェックポイント阻害薬と併用すべき至適殺細胞性抗がん剤の同定を目指した免疫学的解析2023
- Author(s)
  荻野広和、Nguyen Na Thi、香西博之、三橋惇志、塚﨑佑貴、矢葺洋平、尾崎領彦、米田浩人、埴淵昌毅、西岡安彦
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 腫瘍内fibrocyteの同定と機能制御による新規複合がん免疫療法の開発2023
- Author(s)
  三橋惇志、荻野広和、Nguyen Na Thi、矢葺洋平、米田浩人、杉本正道、根東攝、軒原浩、西岡安彦
- Organizer
  第32回日本がん転移学会学術集会・総会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 好酸球増加は免疫チェックポイント阻害薬治療を受けた非小細胞肺癌患者の効果予測バイオマーカー2023
- Author(s)
  竹内栄治、荻野広和、近藤健介、岡野義夫、松村有悟、市原聖也、國重道大、門田直樹、町田久典、畠山暢生、軒原浩、篠原勉、西岡安彦
- Organizer
  第64回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 肺癌における腫瘍浸潤線維細胞の走化因子とその疾患予後に及ぼす影響についての解析2023
- Author(s)
  塚崎佑貴、三橋惇志、尾崎領彦、矢葺洋平、米田浩人、荻野広和、西岡安彦
- Organizer
  第27回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 複合がん免疫療法の Up-To-Date2023
- Author(s)
  荻野広和
- Organizer
  第27回日本がん分子標的治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 悪性胸膜中皮腫に対する抗ポドプラニン抗体および抗CTLA-4抗体による複合がん免疫療法の検討2023
- Author(s)
  米田浩人、三橋惇志、荻野広和、軒原浩、阿部真治、金子美華、加藤幸成、西岡安彦
- Organizer
  第32回日本がん転移学会学術集会・総会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] HIF1A 阻害による腫瘍細胞由来 CXCL10/11 制御を介した抗 PDL1 抗体への耐性克服2023
- Author(s)
  矢葺洋平、三橋惇志、荻野広和、Na T. Nguyen、米田浩人、尾崎領彦、塚崎佑貴、埴淵昌毅、軒原浩、西岡安彦
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] The identification and analysis of fibrocyte regulating the tumor immune microenvironment2023
- Author(s)
  Atsushi Mitsuhashi、Kazuya Koyama、Tania Afroj、Atsuro Saijo、Makoto Tobiume、Hirokazu Ogino、Masamichi Sugimoto、Osamu Kondoh、Hiroshi Nokihara、Yasuhiko Nishioka
- Organizer
  he 9th Joint Meeting 2023 (Tokushima Univ., Gifu Univ., SNU, and IBS-KAIST)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 非小細胞肺癌症例における腫瘍浸潤線維細胞の走化因子と疾患予後との関連性についての解析2023
- Author(s)
  塚崎佑貴、飛梅亮、三橋惇志、尾崎領彦、矢葺洋平、米田浩人、荻野広和、埴淵昌毅、小川博久、滝沢宏光、西岡安彦
- Organizer
  第64回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] IFN-g 反応性ケモカイン産生制御機序の解明と新規複合がん免疫療法への応用2023
- Author(s)
  矢葺洋平、三橋惇志、Nguyen Na Thi、荻野広和、米田浩人、尾崎領彦、西岡安彦
- Organizer
  第27回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] Fibrocyte の分化制御による複合がん免疫療法への展開2023
- Author(s)
  三橋惇志、荻野広和、Nguyen Na Thi、米田浩人、矢葺洋平、杉本正道、根東攝、軒原浩、西岡安彦
- Organizer
  第27回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] フッ化ピリミジンは胸部腫瘍の免疫原性細胞死を誘導し免疫チェックポイント阻害薬の至適併用薬となり得る2023
- Author(s)
  荻野広和、香西博之、三橋惇志、塚崎佑貴、矢葺洋平、尾崎領彦、米田浩人、埴淵昌毅、軒原浩、西岡安彦
- Organizer
  第64回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] PD-1/PD-L1 blockade mediates antiangiogenic effects by tumorderived CXCL10/11 as a potential predictive biomarker2022
- Author(s)
  Atsushi Mitsuhashi, Hirokazu Ogino, Hiroshi Nokihara, Yasuhika Nishioka
- Organizer
  第81回日本癌学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] Eliminates MDSCs and enhances the efficacy of immune checkpoint inhibitor in thoracic tumors2022
- Author(s)
  Na Thi Nguyen, Atsushi Mitsuhashi, Hirokazu Ogino, Hiroyuki Kozai, Hiroto Yoneda, Hiroshi Nokihara, Yasuhiko Nishioka
- Organizer
  第63回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 免疫チェックポイント阻害薬および血管新生阻害薬併用療法における腫瘍内fibrocyteの機能解析2022
- Author(s)
  三橋惇志, 荻野広和, Nguyen Thi Na, 米田浩人, 大塚憲司, 杉本正道, 根東攝, 軒原浩, 西岡安彦
- Organizer
  第26回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] 悪性胸膜中皮腫に対する抗ポドプラニン抗体および抗CTLA-4抗体による複合がん免疫療法の検討2022
- Author(s)
  米田浩人, 三橋惇志, 荻野広和, 尾崎領彦, 矢葺洋平, 軒原浩, 阿部真治, 加藤幸成, 西岡安彦
- Organizer
  第26回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] Fibrocyte drives antitumor immunity via T cell-costimulation in combination immunotherapy2022
- Author(s)
  Atsushi Mitsuhashi, Hirokazu Ogino, Masamichi Sugimoto, Hiroshi Nokihara, Yasuhiko Nishioka
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K24340
[Presentation] Analyses of the immuno-modulatory function of fibrocytes in tumor immunity2019
- Author(s)
  Tania Afroj, Hirokazu Ogino, Makoto Tobiume, Hiroto Yoneda, Masatoshi Kisyuku, Atsuro Saijo, Atsushi Mitsuhashi, Kazuya Koyama, Hisatsugu Goto, Yasuhiko Nishioka.
- Organizer
  第59回日本呼吸器学会学術講演会
- Data Source
  KAKENHI-PROJECT-17K16046
[Presentation] 免疫チェックポイント阻害薬および血管新生阻害薬併用療法における腫瘍内fibrocyte-like cellの機能解析2019
- Author(s)
  三橋惇志、後東久嗣、荻野広和、大塚憲司、杉本正道、根東攝、西岡安彦
- Organizer
  第23回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09657
[Presentation] 血管新生阻害薬耐性とその克服2019
- Author(s)
  西岡安彦、荻野広和、三橋惇志
- Organizer
  第23回日本がん分子標的治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-17K09657
[Presentation] 線維細胞が腫瘍免疫に及ぼす影響についての検討2018
- Author(s)
  荻野広和, 後東久嗣, 大塚憲司, 西條敦郎, 埴淵昌毅, 西岡安彦
- Organizer
  第22回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-17K16046
[Presentation] 当科における免疫チェックポイント阻害薬による薬剤性間質性肺疾患の検討2018
- Author(s)
  三橋惇志，香川耕造，米田浩人，西條敦郎，飛梅亮，荻野広和，近藤真代，髙橋直希，軒原浩，後東久嗣，西岡安彦
- Organizer
  第59回日本呼吸器学会中国・四国地方会／第57回日本肺癌学会中国・四国支部学術集会若手向けの教育セミナー
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 間質性肺炎合併非小細胞肺癌に対する 2 次化学療法の検討2018
- Author(s)
  米田浩人, 大塚憲司, 荻野広和, 西條敦郎, 後東久嗣, 軒原浩, 西岡安彦
- Organizer
  第59回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 間質性肺炎合併未治療進行非小細胞肺癌に対するTS-1+CBDCA併用療法の第Ⅱ相臨床試験2018
- Author(s)
  荻野広和，埴淵昌毅，柿内聡司，安宅信二，大串文隆，清水英治，葉久貴司，大塚憲司，西條敦郎，軒原浩，後東久嗣，西岡安彦
- Organizer
  第16回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 線維細胞が腫瘍免疫に及ぼす影響についての検討2018
- Author(s)
  荻野広和，後東久嗣，大塚憲司，西條敦郎，埴淵昌毅，西岡安彦
- Organizer
  第22回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 肺癌・悪性胸膜中皮腫マウスモデルを用いた免疫チェックポイント阻害薬と化学療法の併用効果に関する検討2018
- Author(s)
  荻野広和，大塚憲司，三橋惇志，木宿昌俊，西岡安彦
- Organizer
  第31回日本バイオセラピィ学会学術集会総会
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 線維細胞が腫瘍免疫に及ぼす影響についての検討2018
- Author(s)
  荻野広和，後東久嗣，大塚憲司，西條敦郎，埴淵昌毅，西岡安彦.
- Organizer
  第22回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-17K16046
[Presentation] Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.2017
- Author(s)
  Atsuro Saijo, Hisatsugu Goto, Mayuri Nakano, Atsushi Mitsuhashi, Hirokazu Ogino, Makoto Tobiume, Kenji Otsuka, Hiroto Yoneda, Masaki Hanibuchi, Yasuhiko Nishioka
- Organizer
  第57回日本呼吸器学会学術講演会
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 骨髄由来線維細胞(fibrocyte)は肺癌のがん幹細胞様特性を促進する2017
- Author(s)
  西條敦郎，後東久嗣，荻野広和，軒原浩，西岡安彦
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] Fibrocytes as a Possible Cellular Biomarker for Anti-Angiogenic Therapy in Lung Cancer.2017
- Author(s)
  H. Goto, A.Mitsuhashi, A. Saijo, H. Ogino, K. Otsuka, M. Tobiume, H. Yoneda, M. Hanibuchi, Y. Nishioka.
- Organizer
  American Thoracic Society 2017 International Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09657
[Presentation] Clinical efficacy of bevacizumab for non-squamous non-small cell lung cancer patients with malignant pleural effusion.2017
- Author(s)
  西條敦郎，荻野広和，大塚憲司，手塚敏史，後東久嗣，埴淵昌毅，西岡安彦
- Organizer
  第15回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 悪性胸膜中皮腫同所移植マウスモデルに対する新規マウス抗ポドプラニン抗体LpMab-21による抗腫瘍効果の検討2017
- Author(s)
  和泉俊尋，阿部真治，荻野広和，後東久嗣，埴淵昌毅，加藤幸成，西岡安彦
- Organizer
  第21回日本がん分子標的学会学術集会
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] Fibrocytes as a Possible Cellular Biomarker for Anti-Angiogenic Therapy in Lung Cancer.2017
- Author(s)
  Hisatsugu Goto, Atsushi Mitsuhashi, Atsuro Saijo, Hirokazu Ogino, Kenji Otsuka, Makoto Tobiume, Hiroto Yoneda, Masaki Hanibuchi, Yasuhiko Nishioka
- Organizer
  ATS 2017 International Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] Bone Marrow-Derived Fibrocytes Promote Stem Cell-Like Properties of Lung Cancer Cells.2017
- Author(s)
  Atsuro Saijo, Hisatsugu Goto, Mayuri Nakano, Atsushi Mitsuhashi, Hirokazu Ogino, Makoto Tobiume, Kenji Otsuka, Hiroto Yoneda, Masaki Hanibuchi, Yasuhiko Nishioka
- Organizer
  ATS 2017 International Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] Phase II study of S-1 with patient-reported outcome evaluation in elderly patients with previously untreated advanced non-small cell lung cancer.2017
- Author(s)
  Hirokazu Ogino, Hisatsugu Goto, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Fumitaka Ogushi, Takashi Haku, Takanori Kanematsu, Tomoyuki Urata, Soji Kakiuchi, Masaki Hanibuchi, Saburo Sone, Yasuhiko Nishioka
- Organizer
  ERS International Congress 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 骨髄由来線維細胞(fibrocyte)は肺癌のがん幹細胞様特性を促進する2016
- Author(s)
  西條敦郎，後東久嗣，三橋惇志，中野万有里，大塚憲司，荻野広和，坂口暁，埴淵昌毅，西岡安彦
- Organizer
  第25回日本がん転移学会学術集会・総会
- Place of Presentation
  米子コンベンションセンター（鳥取県・米子市）
- Year and Date
  2016-07-21
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 悪性胸水を伴った非扁平上皮非小細胞肺癌に対する Bevacizumab 併用化学療法の検討2016
- Author(s)
  西條敦郎，手塚敏史，荻野広和，豊田優子，後東久嗣，埴淵昌毅，西岡安彦
- Organizer
  第57回日本肺癌学会学術集会
- Place of Presentation
  福岡国際会議場（福岡県・福岡市）
- Year and Date
  2016-12-19
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] Receptor tyrosine kinase-like orphan receptor 2, ROR2, regulates the proliferation of malignant pleural mesothelioma cells.2016
- Author(s)
  Ogino H, Goto H, Kakiuchi S, Saijo A, Sakaguchi A, Tobiume M, Otsuka K, Hanibuchi M, Nishioka Y.
- Organizer
  ATS 2016 International Conference
- Place of Presentation
  San Francisco, CA, USA.
- Year and Date
  2016-05-17
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 受容体型チロシンキナーゼROR2は悪性胸膜中皮腫細胞の増殖を制御する2016
- Author(s)
  荻野広和，後東久嗣，西條敦郎，大塚憲司，埴淵昌毅，西岡安彦
- Organizer
  第25回日本がん転移学会学術集会・総会
- Place of Presentation
  米子コンベンションセンター（鳥取県・米子市）
- Year and Date
  2016-07-21
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 徳島大学病院における進展型小細胞肺癌患者の予後因子についての検討2016
- Author(s)
  荻野広和，埴淵　昌毅，大塚　憲司，西條　敦郎，坂口　暁，手塚　敏史，柿内　聡司，後東　久嗣，西岡　安彦
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸国際展示場（兵庫県・神戸市）
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 小細胞肺癌における肝転移の位置づけとがん幹細胞様細胞の役割2016
- Author(s)
  後東久嗣，荻野広和，三橋惇志，西岡安彦
- Organizer
  第25回日本がん転移学会学術集会・総会
- Place of Presentation
  米子コンベンションセンター（鳥取県・米子市）
- Year and Date
  2016-07-22
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 高齢者進行非小細胞肺癌患者を対象としてPRO評価を取り入れたS-1療法の臨床第Ⅱ相試験2016
- Author(s)
  荻野広和，後東久嗣，大串文隆，葉久貴司，兼松貴則，浦田知之，埴淵昌毅，曽根三郎，西岡安彦
- Organizer
  第113回日本内科学会総会・講演会
- Place of Presentation
  東京国際フォーラム（東京都・千代田区）
- Year and Date
  2016-04-15
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] Bone marrow-derived fibrocytes maintain stem cell-like properties of lung cancer.2016
- Author(s)
  Saijo A, Goto H, Mitsuhashi A, Nakano M, Ogino H, Aono Y, Sakaguchi S, Tobiume M, Otsuka K, Hanibuchi M, Nishioka Y.
- Organizer
  ATS 2016 International Conference
- Place of Presentation
  San Francisco, CA, USA.
- Year and Date
  2016-05-15
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 肺癌，悪性胸膜中皮腫に対する免疫チェックポイント阻害剤の有効性の基礎的検討2016
- Author(s)
  大塚憲司，埴淵昌毅，荻野広和，後東久嗣，西岡安彦
- Organizer
  第25回日本がん転移学会学術集会・総会
- Place of Presentation
  米子コンベンションセンター（鳥取県・米子市）
- Year and Date
  2016-07-21
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 当科における高齢者肺癌の若年者との比較検討2016
- Author(s)
  埴淵昌毅，手塚敏史，西條敦郎，荻野広和，後東久嗣，西岡安彦
- Organizer
  第57回日本肺癌学会学術集会
- Place of Presentation
  福岡国際会議場（福岡県・福岡市）
- Year and Date
  2016-12-21
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] 小細胞肺癌における肝転移の位置づけとがん幹細胞様細胞の役割2016
- Author(s)
  後東久嗣, 荻野広和, 三橋惇志, 西岡安彦
- Organizer
  第25回日本がん転移学会学術集会
- Place of Presentation
  米子コンベンションセンター（鳥取県・米子市）
- Data Source
  KAKENHI-PROJECT-15K19420
[Presentation] 徳島大学病院における進展型小細胞肺癌患者の予後因子に関する後ろ向き研究2016
- Author(s)
  荻野広和，後東久嗣，西條敦郎，柿内聡司，埴淵昌毅，西岡安彦
- Organizer
  第57回日本肺癌学会学術集会
- Place of Presentation
  福岡国際会議場（福岡県・福岡市）
- Year and Date
  2016-12-19
- Data Source
  KAKENHI-PROJECT-16H05309
[Presentation] Characterization of Sphere-Forming Stem-Like Population of Lung Cancer Cell Line in Multi-Organ Metastasis Model.2015
- Author(s)
  Hirokazu Ogino, Atsushi Mitsuhashi, Hisatsugu Goto, Atsuro Saijo, Takuya Kuramoto, Sho Tabata, Hisanori Uehara, Soji Kakiuchi, Masaki Hanibuchi, Yasuhiko Nishioka.
- Organizer
  ATS 2015 International Conference.
- Place of Presentation
  Denver, CO (USA)
- Year and Date
  2015-05-19
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19420
[Presentation] Sphere 形成癌幹細胞様分画のヒト肺癌多臓器転移モデルマウスにおける役割についての解析.2015
- Author(s)
  荻野広和, 三橋惇志, 後東久嗣, 西條敦郎, 佐藤正大, 坂口暁, 手塚敏史, 倉本卓哉, 田畑祥, 上原久典, 埴淵昌毅, 西岡安彦.
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場（愛知県・名古屋市）
- Year and Date
  2015-10-10
- Data Source
  KAKENHI-PROJECT-15K19420
[Presentation] Sphere 形成癌幹細胞様分画の肺癌多臓器転移における役割についての解析2015
- Author(s)
  荻野広和, 後東久嗣, 三橋惇志, 西條敦郎, 佐藤正大, 柿内聡司, 埴淵昌毅, 上原久典, 西岡安彦.
- Organizer
  第24回日本がん転移学会学術集会
- Place of Presentation
  シティプラザ大阪（大阪府・大阪市）
- Year and Date
  2015-07-23
- Data Source
  KAKENHI-PROJECT-15K19420

1. 三橋惇志 (00833732)

# of Collaborated Projects: 4 results

# of Collaborated Products: 25 results
2. NISHIOKA Yasuhiko (70274199)

# of Collaborated Projects: 2 results

# of Collaborated Products: 54 results
3. GOTO Hisatsugu (00437641)

# of Collaborated Projects: 2 results

# of Collaborated Products: 26 results
4. 西條敦郎 (00467812)

# of Collaborated Projects: 1 results

# of Collaborated Products: 18 results
5. 埴淵昌毅 (80335794)

# of Collaborated Projects: 1 results

# of Collaborated Products: 20 results
6. 木宿昌俊 (90597501)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 尾崎領彦 (70991561)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 佐藤正大 (80530899)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
9. 小山壱也 (90724089)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
10. AFROJ tania

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. 西村直樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
12. 軒原浩

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

Hirokazu Ogino 荻野 広和

OGINO Hirokazu 荻野 広和

Research Projects

Research Products

Co-Researchers

ヘパラナーゼ制御によるhot tumor誘導と新規がん複合免疫療法の創出

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

腫瘍内線維細胞における時計遺伝子の機能解析と新規複合がん免疫療法開発への応用

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

腫瘍内免疫療法を用いた新規複合がん免疫療法の効果規定因子を同定する試みPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

肺がん・中皮腫における新たな抗原提示細胞の同定から革新的複合がん免疫療法への展開

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The fibrocyte research for clarifying and overcoming the resistance against anti-angiogenesis therapy in lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analyses of the immuno-modulatory function of fibrocytes in tumor immunityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Novel target cells in tumor microenvironment of lung cancer: focusing on fibrocytes to overcome drug resistance and develop the innovative therapy

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of cancer stem cell-like sphere forming cells in multi-organ metastasis of lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] An increased relative eosinophil count as a predictive dynamic biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer2023

Author(s)

Hirokazu Ogino 荻野広和

OGINO Hirokazu 荻野広和